Earnings
Palantir's 16% Surge: Analyzing the Implications of Blowout Earnings and AI Demand
Palantir's shares jumped 16% following strong Q2 earnings, with CEO Alex Karp highlighting significant AI reve…
Aug 4
Earnings
Pfizer's Q2 Performance: A Shift from Covid to Core Products and Future Outlook
Pfizer's Q2 earnings beat estimates, signaling a pivot from Covid-related revenue to strong sales in core prod…
Aug 4
Analysis
Unusual Options Activity Signals Bullish Sentiment for Microsoft
A surge in long-dated call options for Microsoft hints at bullish investor sentiment amid a rising market.
Aug 4
Earnings
Palantir's Earnings Surge: A Bullish Signal for Tech Traders
Palantir's 16% post-Q2 earnings surge signals strong commercial revenue and AI demand, suggesting positive mar…
Aug 4
Earnings
Pfizer's Revenue Guidance Boost: A Shift in Focus
Pfizer beats Q2 estimates, raises revenue guidance, but reduces Covid product revenue expectations.
Aug 4
IPO
Curium-Lantheus Merger: What It Means for the Biotech Sector and Investors
The $8 billion merger between Curium and Lantheus could reshape the radiopharmaceutical landscape, impacting i…
Aug 3
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
More Stories